序号 |
标题 |
次数 |
作者 |
发布时间 |
180901 |
705250-92-6,31 反式-2-(3-(三氟甲氧基)苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
207 |
kx |
2024-03-04 |
180902 |
Gold nanoparticles,Au-PEG-Cholesterol(30nm)胆固醇修饰纳米金30nm |
193 |
zyl |
2024-03-04 |
180903 |
474082-35-4 Amine-PEG10-amine 氨基十聚乙二醇乙胺 |
203 |
wqy |
2024-03-04 |
180904 |
4-(4-(甲氧基羰基)苯乙基)哌嗪-1-羧酸叔丁酯 tert-butyl 4-(4-(methoxycarbonyl)phenethyl) piperazine-1-carboxylate PROTAC |
212 |
zcy |
2024-03-04 |
180905 |
Gold nanoparticles,Au-PEG-Cholesterol(20nm)胆固醇修饰纳米金20nm |
180 |
zyl |
2024-03-04 |
180906 |
2055014-94-1 Propargyl-PEG8-acid;Propargyl-PEG8-COOH 丙炔-八乙二醇-羧酸 |
196 |
wqy |
2024-03-04 |
180907 |
反式-2-(3-硝基-4-(三氟甲氧基)苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
205 |
kx |
2024-03-04 |
180908 |
COOtBu-PEG8-DNP;DNP-PEG8-t-butyl ester |
218 |
wqy |
2024-03-04 |
180909 |
反式-2-(3-氰基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
218 |
kx |
2024-03-04 |
180910 |
1007209-94-0 4-(4-溴苯乙基)哌嗪-1-羧酸叔丁酯 PROTAC(蛋白降解靶向嵌合体) |
220 |
zcy |
2024-03-04 |
180911 |
Boc-NH-PEG8-DNP 分子式 C29H50N4O14 |
201 |
wqy |
2024-03-04 |
180912 |
84913-19-9 4-甲基苯磺酸4-溴苯乙酯 PROTAC(蛋白降解靶向嵌合体) |
238 |
zcy |
2024-03-04 |
180913 |
16633-45-7,93 反式-2-(3-氯苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
213 |
kx |
2024-03-04 |
180914 |
Gold nanoparticles,Au-PEG-Cholesterol(15nm)胆固醇修饰纳米金15nm |
188 |
zyl |
2024-03-04 |
180915 |
2227899-38-7,63 反式-2-(3-氯-5-氟苯基)环丙烷-1-羧酸 ,PROTAC(蛋白降解靶向嵌合体) |
231 |
kx |
2024-03-04 |
180916 |
4-氯-N-(2-(2,6-二氧杂哌啶-3-基)-1,3-二氧异吲哚-4-基)丁酰胺 4-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)butanamide PROTAC |
234 |
zcy |
2024-03-04 |
180917 |
Azide-PEG8-DNP 分子式 C24H40N6O12 |
203 |
wqy |
2024-03-04 |
180918 |
Gold nanoparticles,Au-PEG-Cholesterol(10nm)胆固醇修饰纳米金10nm |
224 |
zyl |
2024-03-04 |
180919 |
COOtBu-PEG8-DNP;DNP-PEG8-t-butyl ester |
193 |
wqy |
2024-03-04 |
180920 |
4-氯-N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧异吲哚-5-基)丁酰胺 4-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)butanamide PROTAC |
227 |
zcy |
2024-03-04 |
180921 |
Boc-NH-PEG8-DNP C29H50N4O14 |
208 |
wqy |
2024-03-04 |
180922 |
Gold nanoparticles,Au-PEG-Cholesterol(10nm)胆固醇修饰纳米金10nm |
187 |
zyl |
2024-03-04 |
180923 |
2227914-40-9,69 反式-2-(3-氯-5-氟苯基)环丙-1-胺盐酸盐,PROTAC(蛋白降解靶向嵌合体) |
217 |
kx |
2024-03-04 |
180924 |
220353-93-5,65 反式-2-(3-氯-4-甲基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
245 |
kx |
2024-03-04 |
180925 |
51908-64-6 4-氯-1-丁炔 PROTAC(蛋白降解靶向嵌合体) |
249 |
zcy |
2024-03-04 |
180926 |
Amine-PEG8-DNP 分子式 C24H42N4O12 |
223 |
wqy |
2024-03-04 |
180927 |
Gold nanoparticles,Au-PEG-Cholesterol(5nm)胆固醇修饰纳米金5nm |
230 |
zyl |
2024-03-04 |
180928 |
2055042-66-3 Hydroxy-PEG9-t-butyl ester 羟基九聚乙二醇丙酸叔丁酯 |
182 |
wqy |
2024-03-04 |
180929 |
反式-2-(3-氟-5-(三氟甲基)苯基)环丙基)甲醇,PROTAC(蛋白降解靶向嵌合体) |
211 |
kx |
2024-03-04 |
180930 |
chitosan modified Au nanoparticles(100nm)壳聚糖修饰金纳米颗粒(100nm) |
222 |
zyl |
2024-03-04 |
180931 |
6790-9-6 Dodecaethylene glycol 十二聚乙二醇 |
216 |
wqy |
2024-03-04 |
180932 |
1334170-02-3 NHS-PEG7-NHS ester;活性酯七聚乙二醇活性酯 |
206 |
wqy |
2024-03-04 |
180933 |
63200-68-0 4-氨基丁-2-炔-1-醇 PROTAC(蛋白降解靶向嵌合体) |
200 |
zcy |
2024-03-04 |
180934 |
1609290-12-1,80 反式-2-(3-氟-4-甲氧基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
217 |
kx |
2024-03-04 |
180935 |
1333154-77-0 azido-PEG7-amine;叠氮七聚乙二醇氨基 |
215 |
wqy |
2024-03-04 |
180936 |
887587-18-0 4-(哌嗪-1-羰基)哌啶-1-羧酸叔丁酯 PROTAC(蛋白降解靶向嵌合体) |
249 |
zcy |
2024-03-04 |
180937 |
94376-75-7 Bis-PEG7-acid;Acid-PEG-acid 羧基七聚乙二醇羧基 |
225 |
wqy |
2024-03-04 |
180938 |
211859-75-5 m-PEG10-OTs;甲氧基-十聚乙二醇-对甲苯磺酸酯 |
211 |
wqy |
2024-03-04 |
180939 |
反式-2-(3-乙基苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
217 |
kx |
2024-03-04 |
180940 |
2168540-65-4 mPEG11-OH 十一聚乙二醇单甲醚 |
210 |
wqy |
2024-03-04 |
180941 |
chitosan modified Au nanoparticles(80nm)壳聚糖修饰金纳米颗粒(80nm) |
242 |
zyl |
2024-03-04 |
180942 |
2308496-47-9 4-(哌啶-4-基乙炔基)苯甲酸甲酯 PROTAC(蛋白降解靶向嵌合体) |
196 |
zcy |
2024-03-04 |
180943 |
反式-2-(3,5-双(三氟甲基)苯基)环丙烷-1-羧酸,PROTAC(蛋白降解靶向嵌合体) |
205 |
kx |
2024-03-04 |
180944 |
chitosan modified Au nanoparticles(60nm)壳聚糖修饰金纳米颗粒(60nm) |
257 |
zyl |
2024-03-04 |
180945 |
Boc-NH-PEG8-azide;BocNH-PEG8-CH2CH2N3 叠氮-八聚乙二醇-氨基叔丁氧羰基 |
200 |
wqy |
2024-03-04 |